Cargando…

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease

BACKGROUND: Identifying predictors of incident cognitive impairment (CI), one of the most problematic long‐term outcomes, in Parkinson's disease (PD) is highly relevant for personalized medicine and prognostic counseling. The Nonmotor Symptoms Scale (NMSS) provides a global clinical assessment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oikonomou, Panteleimon, van Wamelen, Daniel J., Weintraub, Daniel, Aarsland, Dag, Ffytche, Dominic, Martinez‐Martin, Pablo, Rodriguez‐Blazquez, Carmen, Leta, Valentina, Borley, Corinne, Sportelli, Carolina, Trivedi, Dhaval, Podlewska, Aleksandra M., Rukavina, Katarina, Rizos, Alexandra, Lazcano‐Ocampo, Claudia, Ray Chaudhuri, Kallol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119808/ https://www.ncbi.nlm.nih.gov/pubmed/33645912 http://dx.doi.org/10.1002/brb3.2086

Ejemplares similares

Drooling in Parkinson’s Disease: Prevalence and Progression from the Non-motor International Longitudinal Study
por: van Wamelen, Daniel J., et al.
Publicado: (2020)

Non-motor correlates of wrist-worn wearable sensor use in Parkinson’s disease: an exploratory analysis
por: van Wamelen, Daniel J., et al.
Publicado: (2019)

Nonmotor Symptoms of Parkinson's Disease
por: Rektorova, Irena, et al.
Publicado: (2011)

The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone
por: Leta, Valentina, et al.
Publicado: (2023)

Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson’s disease
por: van Wamelen, Daniel J., et al.
Publicado: (2019)

Characterization of Non‐Motor Fluctuations Using the Movement Disorder Society Non‐Motor Rating Scale
por: van Wamelen, Daniel Johannes, et al.
Publicado: (2022)

Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of Dopamine
por: Dave, Sonali, et al.
Publicado: (2019)

Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery?
por: Chaudhuri, K. Ray, et al.
Publicado: (2013)

Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism
por: Leta, Valentina, et al.
Publicado: (2022)

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
por: Seppi, Klaus, et al.
Publicado: (2019)

Ethnic Disparities in Treatment of Chronic Pain in Individuals with Parkinson's Disease Living in the United Kingdom
por: Rukavina, Katarina, et al.
Publicado: (2022)

Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease
por: Buhidma, Yazead, et al.
Publicado: (2020)

Parkinson's disease and Covid-19: The effect and use of telemedicine
por: Podlewska, Aleksandra M., et al.
Publicado: (2022)

Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care
por: Rukavina, Katarina, et al.
Publicado: (2022)

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease
por: Batzu, Lucia, et al.
Publicado: (2022)

Light, sleep‐wake rhythm, and behavioural and psychological symptoms of dementia in care home patients: Revisiting the sundowning syndrome
por: Guu, Ta‐Wei, et al.
Publicado: (2022)

Nonmotor Symptoms of Parkinson's Disease
por: Wu, Shey-Lin, et al.
Publicado: (2017)

Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s disease
por: Urso, Daniele, et al.
Publicado: (2021)

Ceruloplasmin in Parkinson's disease and the nonmotor symptoms
por: Zhao, Xuemei, et al.
Publicado: (2018)

Nonmotor symptoms in spinocerebellar ataxias (SCAs)
por: Moro, Adriana, et al.
Publicado: (2019)

Nonmotor Symptoms in Dystonia: Pathophysiological Implications
por: Mishra, Anumeha, et al.
Publicado: (2020)

Parkinson's Disease and Post–COVID‐19 Syndrome: The Parkinson's Long‐COVID Spectrum
por: Leta, Valentina, et al.
Publicado: (2021)

Nonmotor Symptoms in Patients with PARK2 Mutations
por: Yoritaka, Asako, et al.
Publicado: (2011)

Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease
por: Park, Ariane, et al.
Publicado: (2011)

Neuropathology and Neurochemistry of Nonmotor Symptoms in Parkinson's Disease
por: Ferrer, Isidro
Publicado: (2011)

Mindfulness for Motor and Nonmotor Dysfunctions in Parkinson's Disease
por: Dissanayaka, Nadeeka N. W., et al.
Publicado: (2016)

Evaluation of Nonmotor Symptoms in Diagnosis of Parkinsonism and Tremor
por: Evans, Andrew H., et al.
Publicado: (2016)

Characteristics of Nonmotor Symptoms in Progressive Supranuclear Palsy
por: Ou, Ruwei, et al.
Publicado: (2016)

Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease
por: Lawn, Timothy, et al.
Publicado: (2021)

Spotlight on non-motor symptoms and Covid-19
por: Rota, Silvia, et al.
Publicado: (2022)

Identifying Parkinson’s disease subtypes with motor and non-motor symptoms via model-based multi-partition clustering
por: Rodriguez-Sanchez, Fernando, et al.
Publicado: (2021)

Nonmotor Symptoms in a Malaysian Parkinson's Disease Population
por: Azmin, Shahrul, et al.
Publicado: (2014)

Effect of Exercise on Motor and Nonmotor Symptoms of Parkinson's Disease
por: Dashtipour, Khashayar, et al.
Publicado: (2015)

Effects of safinamide on pain in patients with fluctuating Parkinson's disease
por: Grigoriou, Sotirios, et al.
Publicado: (2021)

Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson’s disease
por: Lau, Yue Hui, et al.
Publicado: (2022)

Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?
por: Rota, Silvia, et al.
Publicado: (2022)

Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms
por: Mack, Josiel Mileno, et al.
Publicado: (2016)

Cortical thinning in patients with REM sleep behavior disorder is associated with clinical progression
por: Pereira, Joana B., et al.
Publicado: (2019)

Nonmotor Symptoms Groups in Parkinson's Disease Patients: Results of a Pilot, Exploratory Study
por: Perez Lloret, Santiago, et al.
Publicado: (2011)

Clinical trajectories and biomarkers for weight variability in early Parkinson’s disease
por: Urso, Daniele, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rq6m1mor7moa44ve6c1n2rqlih